Sarah Cannon Research Institute’s Drug Development Program offers sponsors consistent performance and research excellence through strict adherence to eligibility criteria, a dedicated pharmacokinetic team, rapid accrual and interactive scientific collaboration.

Participation in a clinical trial is the first step in fighting cancer, not the last.®

Services and Resources

  • Extensive clinical trials menu
  • Expansive clinic with patient waiting area
  • Private treatment room
  • On-site pharmacy for patient convenience
  • Wireless internet and televisions with wireless headphones

Program Growth

Sarah Cannon’s drug development program has conducted 600+ first-in-human clinical trials and experienced an annual average growth rate of 15-20 percent in patient enrollment. We are committed to our partners’ goals, and we tailor our teams and processes to meet them.

Senior-level management and clinical staff stay involved throughout our working relationship, ensuring strong science and consistent quality every step of the way. We serve as collaborators and research consultants, and we strive to provide informed scientific insights that contribute to success, discovery, and faster answers.